-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Depression in vascular pathologies: the neurologist's point of view
Review
(1340) Views (442) Full article downloads
Authors: Moretti R, Bernobich E, Esposito F, Torre P, Antonello RM, De Angelis L, Bellini G
Published Date July 2011
Volume 2011:7 Pages 433 - 443
DOI: http://dx.doi.org/10.2147/VHRM.S20147
Rita Moretti, Elena Bernobich, Francesca Esposito, Paola Torre, Rodolfo M Antonello, Luisa De Angelis, Giuseppe BelliniMedicina Clinica, Ambulatorio Complicanze Internistiche Cerebrali, Dipartimento Universitario Clinici di scienze Mediche Tecnologiche e Traslazionali, Università degli Studi di Trieste, Trieste, Italy
Abstract: The coexistence of depression and cardiovascular disease (CVD) is regularly discussed, and much debated. There is strong evidence that there are pathophysiological mechanisms, particularly endothelial dysfunction, altered platelet aggregation, and hyperactivation of the thrombosis cascade, which coexist with hypothalamic-pituitary-adrenocortical axis dysfunction, and link depression to CVD. Therefore, depression should not be automatically considered to be a consequence of life impairment due to myocardial infarction or major stroke. Probably, it should be considered as one of the many other stressful events, or “genetic reactions to life”, which are risk factors for CVD development. This review will examine the significance of depression in clinical daily practice, its pathophysiology as a determinant in vascular events, and its real importance in, before, and after many CVD events.
Keywords: depression, cardiovascular disease, stressful events, cardiovascular risks
Other articles by Dr R moretti
Readers of this article also read:
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography
Erratum - Intracellular heavy metal nanoparticle storage
Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications
Stentless aortic valve replacement: an update
Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?
Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review




